14 July 2014

Alex Palazzo and Trevor Moraes promoted!

We were delighted to learn that Drs. Alex Palazzo and Trevor Moraes have been promoted to Associate Professor with Tenure in recognition of their "outstanding contributions to the Department and the University and of their promise for future scientific leadership." The Department extends its warmest congratulations on their achievement!

Biochemistry with a Medical Perspective is an online, university level course taught by faculty from the Department of Biochemistry through a series of intensive, illustrated video lectures. The course is scheduled three times a year.

The course is open to Canadian and international students, professionals and private individuals.  The course is not open to full or part-time students enrolled at the University of Toronto.

**NEW** SCS 2472: Biochemistry with a Medical Perspective is acceptable as a prerequisite for one of the two full-course equivalents in any life science for admission into Medical School at the University of Toronto.
Learn more on the course website.

Read all the News & Events

09 May 2014

Alex Palazzo on Junk DNA

Dr. Palazzo in collaboration with T. Ryan Gregory from the University of Guelph published a perspective on “The Case for Junk DNA” that appeared in the May issue of PLoS Genetics and is highlighted in on the National Geographic website.

April 2014

Trevor Moraes and Alex Palazzo receive Early Research Awards

Congratulations to Trevor Moraes and Alex Palazzo who were selected by the Ontario Ministry of Research and Innovation to obtain Early Research Awards. Professor Moraes received the award to help develop antimicrobials through the structural investigation of membrane proteins, while Professor Palazzo will use the funding to continue his research into how mRNAs that encode secretory proteins are exported from the nucleus and translated into proteins.

23 March 2014

Igor Stagljar and colleagues identify a novel biomarker for the most common form of lung cancer

Appearing in the March 23rd issue of Nature Methods, the Stagljar lab developed the mammalian membrane two-hybrid (MaMTH) assay and applied it to the human epidermal growth receptor (EGFR), mutations of which are associated with lung cancer. Using this approach, they identified CrkII as an interactor of the mutated EGFR and showed that Crk II regulates the stability of mutated EGFR and thus promotes signaling within cancer cells Read more in the U. of T. News article.

Read all the Research News